The mechanism of ranolazine action to reduce ischemia-induced diastolic dysfunction
Pharmacology and Translational Biomedical Research, CV Therapeutics Inc., 3172 Porter Drive, Palo Alto, CA 94304, USA
* Corresponding author. Tel: +1 650 384 8526; fax: +1 650 475 0450. E-mail address: luiz.belardinelli{at}cvt.com
Ischaemia of myocardium is associated with increases in the late sodium current (INa), intracellular sodium and calcium concentrations, calcium overload, and impairment of contractile relaxation (i.e. increased diastolic wall tension). An increase in diastolic wall tension compresses the vasculature and reduces nutritive blood flow, creating a positive feedback system that further impairs myocardial oxygenation and contractile function. Ranolazine reduces the late INa and, is expected to decrease sodium entry into ischaemic myocardial cells. As a consequence, ranolazine is proposed to reduce calcium uptake indirectly via the sodium/calcium exchanger and to preserve ionic homeostasis and reverse ischaemia-induced contractile dysfunction.
Key Words: Late INa Ischaemia Diastole Angina Calcium overload Persistent sodium current Ranolazine